BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31236153)

  • 21. Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.
    Diamantopoulos LN; Holt SK; Khaki AR; Sekar RR; Gadzinski A; Nyame YA; Vakar-Lopez F; Tretiakova MS; Psutka SP; Gore JL; Lin DW; Schade GR; Hsieh AC; Lee JK; Yezefski T; Schweizer MT; Cheng HH; Yu EY; True LD; Montgomery RB; Grivas P; Wright JL
    Clin Genitourin Cancer; 2021 Apr; 19(2):144-154. PubMed ID: 33160889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Untangling the complexities of micropapillary cancer
    Charles Campbell F
    J Pathol; 2021 Dec; 255(4):343-345. PubMed ID: 34564856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
    Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
    FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen metabolism in brain and neurons - astrocytes metabolic cooperation can be altered by pre- and neonatal lead (Pb) exposure.
    Baranowska-Bosiacka I; Falkowska A; Gutowska I; Gąssowska M; Kolasa-Wołosiuk A; Tarnowski M; Chibowska K; Goschorska M; Lubkowska A; Chlubek D
    Toxicology; 2017 Sep; 390():146-158. PubMed ID: 28916327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1.
    Pescador N; Villar D; Cifuentes D; Garcia-Rocha M; Ortiz-Barahona A; Vazquez S; Ordoñez A; Cuevas Y; Saez-Morales D; Garcia-Bermejo ML; Landazuri MO; Guinovart J; del Peso L
    PLoS One; 2010 Mar; 5(3):e9644. PubMed ID: 20300197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
    Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
    Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
    Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma.
    Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A
    Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer.
    Compérat E; Roupret M; Conort P; Chartier-Kastler E; Bitker MO; Richard F; Capron F; Haertig A; Cussenot O; Camparo P
    Urol Int; 2009; 82(3):312-7. PubMed ID: 19440020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.
    Ohtsuki Y; Ochi K; Okada Y; Kato M; Lee GH; Furihata M
    Med Mol Morphol; 2008 Jun; 41(2):113-6. PubMed ID: 18592166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases.
    Roh JH; Srivastava A; Lauwers GY; An J; Jang KT; Park CK; Sohn TS; Kim S; Kim KM
    Am J Surg Pathol; 2010 Aug; 34(8):1139-46. PubMed ID: 20661012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
    Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Micropapillary Carcinoma in the Sigmoid Colon].
    Konaka Y; Ueda M; Takenaka A; Yamada T; Nakano Y; Adachi Y
    Gan To Kagaku Ryoho; 2019 Nov; 46(11):1787-1790. PubMed ID: 31748494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
    Kuai XY; Lei ZY; Liu XS; Shao XY
    Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
    Varesano S; Zocchi MR; Poggi A
    Front Immunol; 2018; 9():998. PubMed ID: 29867975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.
    Imai H; Kaira K; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Kosaka T; Yajima T; Ohtaki Y; Osaki T; Kogure Y; Tanaka S; Fujita A; Oyama T; Minato K; Asao T; Shirabe K
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.